Dr Karin Oien, Clinical Senior Lecturer in Pathology at the Institute of Cancer Sciences, University of Glasgow and recently appointed…
Developing the UK research strategy for Proton Beam Therapy
'Thanks to a £250m investment from the UK government, the first of two NHS Proton Beam Therapy (PBT) centres has…
Appointment of new NCRI Consumer Lead
'We are pleased to announce that Emma Kinloch has been appointed as NCRI Consumer Lead, effective from 1 April 2019.…
CM-Path at the NCRI Conference – Translational Research
'Report from the NCRI Conference Best of Translational Science; Pancreatic research Author: Hayley Morris, CM-Path Workstream 1 member During this…
CM-Path at the NCRI Conference – Digital Pathology
'Find out about what CM-Path members heard and the activities they took part in over the NCRI conference 2018 in…
CM-Path at the NCRI Conference – Biobanking
'Find out about what CM-Path members heard and the activities they took part in over the NCRI conference 2018 in…
NCRI to partner with new AI tech centres across the UK
'This month, the government announced £50m of funding towards the creation of five new centres of excellence for digital pathology…
Why our living with and beyond cancer research initiative matters
'Over the last year, Ceinwen Giles has been involved with the NCRI’s Living with and Beyond Cancer Research Initiative to…
Top 10 research priorities for living better with and beyond cancer in the UK
'Professor Diana Greenfield, Consultant Nurse at Sheffield Teaching Hospital NHS Foundation Trust was part of the Steering Group that advised…
Gap in research means millions living with long-term consequences of cancer
'Millions of people are living with the long-term consequences of cancer and its treatment, but currently there is very little…
What the living with and beyond cancer research priorities mean to me – Richard Stephen’s story
'“Vaseline, ginger beer, soft-bristled toothbrush, ginger biscuits, baby shampoo, and put ginger in your food. ” That was the shopping…
Men with prostate cancer are willing to accept lower survival odds to side effects
'Men who have been newly diagnosed with prostate cancer say they would trade some improvement in their odds of survival…